A social justice perspective on access to human rabies vaccines.

A social justice perspective on access to human rabies vaccines.
复制标题

DOI:
10.1016/j.vaccine.2019.01.065
复制
发表时间:
2019-10-03
期刊:
影响因子:
5.5
通讯作者:
Chng NR
Chng NR
中科院分区:
医学3区
文献类型:
--
作者:
Wentworth D;Hampson K;Thumbi SM;Mwatondo A;Wambura G;Chng NR

文献摘要

参考文献

被引文献

相似文献

狂犬病每年导致数万人死亡,尽管完全可以通过疫苗预防。全球主要的卫生行动者已经启动了一项国家驱动的计划,到2030年在全球范围内实现由狗介导的狂犬病造成的零人类死亡。最近,全球疫苗免疫联盟(Gavi)决定投资用于暴露后预防(PEP)的人类狂犬病疫苗,从而加强了这种合作伙伴关系。虽然民族国家是消灭狂犬病的关键,但Gavi的作用的重要性不容低估。与任何其他参与者不同,Gavi可以直接解决狂犬病PEP供应不足的市场失灵问题。在这篇评论中,我们采用能力方法来确定导致这种市场失灵的PEP准入障碍,并因此导致不必要的死亡和痛苦。我们展示了Gavi在减少PEP供应对市场力量的暴露方面可以发挥的作用,这是一个社会正义问题,因此纠正了人类狂犬病死亡背后的不公平现象。
Rabies kills tens of thousands of people every year despite being entirely vaccine preventable. Key global health actors have launched a country-driven plan to achieve zero human deaths from dog-mediated rabies by 2030 worldwide. This partnership has recently been strengthened by Gavi, the Vaccine Alliance’s decision to invest in human rabies vaccines for post-exposure prophylaxis (PEP). While nation states are key to rabies elimination, the importance of Gavi’s role cannot be understated. Unlike any other actor, Gavi can directly address an otherwise intractable market failure in the inadequate supply of rabies PEP. In this commentary, we employ the Capabilities Approach to identify the barriers to PEP access that lead to this market failure and, as a result, unnecessary deaths and suffering. We show the role that Gavi can play in reducing exposure of PEP supply to market forces as a matter of social justice, and hence redress the inequity underlying human rabies deaths.
DOI: 10.1371/journal.pntd.0003709
发表时间: 2015-04
影响因子: 3.8
作者:
Hampson K;Coudeville L;Lembo T;Sambo M;Kieffer A;Attlan M;Barrat J;Blanton JD;Briggs DJ;Cleaveland S;Costa P;Freuling CM;Hiby E;Knopf L;Leanes F;Meslin FX;Metlin A;Miranda ME;Müller T;Nel LH;Recuenco S;Rupprecht CE;Schumacher C;Taylor L;Vigilato MA;Zinsstag J;Dushoff J;Global Alliance for Rabies Control Partners for Rabies Prevention
通讯作者: Global Alliance for Rabies Control Partners for Rabies Prevention
柬埔寨的狂犬病情况。
DOI: 10.1371/journal.pntd.0000511
发表时间: 2009-09-08
影响因子: 3.8
作者:
Ly, Sowath;Buchy, Philippe;Heng, Nay Yim;Ong, Sivuth;Chhor, Nareth;Bourhy, Herve;Vong, Sirenda
通讯作者: Vong, Sirenda
DOI: 10.1016/j.vaccine.2018.10.011
发表时间: 2019-10-03
期刊: VACCINE
影响因子: 5.5
作者:
Li, Anyie J.;Sreenivasan, Nandini;Hyde, Terri B.
通讯作者: Hyde, Terri B.
DOI: 10.1098/rstb.2016.0168
发表时间: 2017-07-19
期刊: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
影响因子: --
作者:
Cleaveland S;Sharp J;Abela-Ridder B;Allan KJ;Buza J;Crump JA;Davis A;Del Rio Vilas VJ;de Glanville WA;Kazwala RR;Kibona T;Lankester FJ;Lugelo A;Mmbaga BT;Rubach MP;Swai ES;Waldman L;Haydon DT;Hampson K;Halliday JEB
通讯作者: Halliday JEB
DOI: 10.1016/j.vaccine.2018.08.086
发表时间: 2019-10-03
期刊: Vaccine
影响因子: 5.5
作者:
Changalucha J;Steenson R;Grieve E;Cleaveland S;Lembo T;Lushasi K;Mchau G;Mtema Z;Sambo M;Nanai A;Govella NJ;Dilip A;Sikana L;Ventura F;Hampson K
通讯作者: Hampson K